CLL cells are highly dependent on aberrant apoptosis mechanisms (e.g., BCL2 upregulation) and pro-survival signaling, such as B-cell receptor (BCR) and NF-κB pathways for disease progression [1–6]. This evidence concerns the gene BCR and B-cell chronic lymphocytic leukemia.